These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2537716)

  • 41. Somatostatin analogue and tissue cultures in the study of a human malignant glucagonoma.
    Ahlman H; Ahlund L; Dahlström A; Grimelius L; Theodorsson E
    J Surg Oncol; 1990 Jul; 44(3):191-9. PubMed ID: 2164620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Somatostatin analogue: use in the treatment of vipoma with hypercalcemia.
    Venkatesh S; Vassilopoulou-Sellin R; Samaan NA
    Am J Med; 1989 Sep; 87(3):356-7. PubMed ID: 2549791
    [No Abstract]   [Full Text] [Related]  

  • 43. Somatostatin analogues in the management of benign insulinomas.
    Laron Z
    Isr J Med Sci; 1990 Jan; 26(1):1-2. PubMed ID: 2155883
    [No Abstract]   [Full Text] [Related]  

  • 44. [Short-term treatment of a VIPoma with somatostatin analogue in advance of curative operation].
    Yoshioka M; Sakazume M; Fukagawa M; Seki T
    Nihon Naika Gakkai Zasshi; 1988 Aug; 77(8):1276-7. PubMed ID: 2853716
    [No Abstract]   [Full Text] [Related]  

  • 45. Resistance of metastatic pancreatic endocrine tumours after long-term treatment with the somatostatin analogue octreotide (SMS 201-995).
    Wynick D; Anderson JV; Williams SJ; Bloom SR
    Clin Endocrinol (Oxf); 1989 Apr; 30(4):385-8. PubMed ID: 2557179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perioperative use of long-acting somatostatin analog (SMS 201-995) in patients with endocrine tumors of the gastroenteropancreatic axis.
    Tsai ST; Eckhauser FE; Thompson NW; Strodel WE; Vinik AI
    Surgery; 1986 Oct; 100(4):788-95. PubMed ID: 2876529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of somatostatin analog in gastroenteropancreatic tumors other than carcinoid.
    Vinik AI; Lloyd R; Cho K
    Metabolism; 1990 Sep; 39(9 Suppl 2):156-62. PubMed ID: 2402220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug?
    Stehouwer CD; Lems WF; Fischer HR; Hackeng WH
    Neth J Med; 1989 Aug; 35(1-2):86-94. PubMed ID: 2550827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport.
    Santangelo WC; O'Dorisio TM; Kim JG; Severino G; Krejs GJ
    Ann Intern Med; 1985 Sep; 103(3):363-7. PubMed ID: 2862821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Vipoma in an adolescent: treatment with a delayed-action somatostatin analog, octreotide or SMS 201-995, and surgical removal].
    Brichard B; Fiasse R; Buts JP; Clapuyt P; Maes M; Rahier J; Cornu G
    Acta Gastroenterol Belg; 1990; 53(2):188-97. PubMed ID: 2176428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin).
    Stehouwer CD; Lems WF; Fischer HR; Hackeng WH; Naafs MA
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):34-40. PubMed ID: 2545062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Drug therapy of endocrine neoplasms. Part II: Malignant gastrinomas, insulinomas, glucagonomas, carcinoids and other tumors].
    Schott M; Scherbaum WA; Feldkamp J
    Med Klin (Munich); 2000 Feb; 95(2):81-4. PubMed ID: 10714123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
    Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
    Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An important new treatment for carcinoid tumors and VIPomas.
    Oncology (Williston Park); 1988 Dec; 2(12):35-6. PubMed ID: 2856315
    [No Abstract]   [Full Text] [Related]  

  • 55. [Attempt in treating benign insulinoma by delayed somatostatin. 2 cases].
    Picq R; Vialettes B; de la Tour d'Auvergne M; Joliot AY; Vague P
    Presse Med; 1988 Nov; 17(39):2087. PubMed ID: 2849769
    [No Abstract]   [Full Text] [Related]  

  • 56. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
    Moattari AR; Cho K; Vinik AI
    Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Long-acting somatostatin analog SMS 201-955 (Sandostatin) and its application in clinical gastroenterological practice].
    Meier R; Gyr K
    Schweiz Rundsch Med Prax; 1988 Aug; 77(31-32):813-9. PubMed ID: 2845555
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera.
    Ruskoné A; René E; Chayvialle JA; Bonin N; Pignal F; Kremer M; Bonfils S; Rambaud JC
    Dig Dis Sci; 1982 May; 27(5):459-66. PubMed ID: 6122550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
    Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
    J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones.
    Osei K; O'Dorisio TM
    Ann Intern Med; 1985 Aug; 103(2):223-5. PubMed ID: 2861769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.